BlueSync Field Evaluation

CompletedOBSERVATIONAL
Enrollment

257

Participants

Timeline

Start Date

April 2, 2018

Primary Completion Date

December 29, 2019

Study Completion Date

December 29, 2019

Conditions
Bradycardia
Interventions
OTHER

Evaluation Group

Patient receiving exposure to the MyCareLink Heart App during device pairing

OTHER

Control Group (Historical)

Patients receiving exposure to the CareLink Monitor 2490 (Excluding wireless model 2490C). The patients' data will be extracted from Medtronic de-identified CareLink™ database.

Trial Locations (20)

27401

Cone Health, Greensboro

32114

Daytona Heart Group, Daytona Beach

32822

Cardiovascular Institutes of Orland0, Orlando

37024

Ospedale Sacro Cuore, Negrar

37934

East Tennessee Consultants, Knoxville

43213

Mount Carmel, Columbus

44195

Cleveland Clinic, Cleveland

56303

CentraCare, Saint Cloud

66160

University of Kansas Medical Center, Kansas City

94305

Stanford Universithy, Palo Alto

06102

Hartford Hosital, Hartford

07450

The Valley Hospital, Ridgewood

Unknown

CHU Bordeaux, Bordeaux

CHI Toulouse, Toulouse

Istituto clinico Città Studi, Milan

Provincia Religiosa San Pietro Di Roma, Rome

University Hospital of North Midlands NHS Trust, Stoke-on-Trent

B71 4HJ

Sandwell and West Birmingham Hospitals, Birmingham

M139WC

Manchester Royal Infirmary, Manchester

SO166YD

Southampton, Southampton

All Listed Sponsors
lead

Medtronic Cardiac Rhythm and Heart Failure

INDUSTRY

NCT03518658 - BlueSync Field Evaluation | Biotech Hunter | Biotech Hunter